Joanne Quan - 21 Jan 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Christopher Peetz, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
21 Jan 2025
Net transactions value
$0
Form type
4
Filing time
23 Jan 2025, 17:55:05 UTC
Previous filing
21 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 21 Jan 2025 Common Stock 40,000 $47.98 Direct F1
transaction MIRM Restricted Stock Units Award $0 +10,000 $0.000000 10,000 21 Jan 2025 Common Stock 10,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vest one year after January 21, 2025 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.